CompletedNot Applicable

Hospital Outcomes: Intervention in Moderately III Patients

United States444 participantsStarted 1998-09

Plain-language summary

To evaluate the utility of real time prognostic data (illness severity, stability and function) in the improvement of hospitalization morbidity, mortality, iatrogenic complications and length of stay.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. All medical in-patients who are coded moderately ill with fair to poor function in the SIGNOUT program will be asked to participate in our study.
✓. Patients who are able to provide verbal consent for their participation will be enrolled.

Exclusion criteria

✕. Any patient not coded in the SIGNOUT system as moderately ill with fair to poor function.
✕. Patients who refuses not to participate in the study.
✕. Patients who are unable to give written informed consent.

What they're measuring

To evaluate the utility of real time prognostic data and in the improvement of hospitalization morbidity, mortality, iatrogenic complications, and length of stay.

Trial details

NCT IDNCT00256659

SponsorWeill Medical College of Cornell University

Sponsor typeOTHER

Study typeINTERVENTIONAL

View on ClinicalTrials.gov More Moderately Ill Medical Inpatients at the Cornell Campus of the New York-Presbyterian Hospital trials